Vertex Pharmaceuticals (VRTX) Net Cash Flow (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 244.69% |
| Dec 31, 2025 | 540.86% |
| Sep 30, 2025 | -112.57% |
| Jun 30, 2025 | 189.48% |
| Mar 31, 2025 | 113.16% |
| Dec 31, 2024 | -199.10% |
| Sep 30, 2024 | 113.86% |
| Jun 30, 2024 | -285.40% |
| Mar 31, 2024 | -53.86% |
| Dec 31, 2023 | -178.29% |
| Sep 30, 2023 | 16.27% |
| Jun 30, 2023 | 169.02% |
| Mar 31, 2023 | -194.92% |
| Dec 31, 2022 | 153.22% |
| Sep 30, 2022 | -54.61% |
| Jun 30, 2022 | 39.05% |
| Mar 31, 2022 | 54.31% |
| Dec 31, 2021 | 141.18% |
| Sep 30, 2021 | 188.53% |
| Jun 30, 2021 | -174.94% |
| Mar 31, 2021 | -46.24% |
| Dec 31, 2020 | 17.52% |
| Sep 30, 2020 | -57.81% |
| Jun 30, 2020 | 152.18% |
| Mar 31, 2020 | 268.52% |
| Dec 31, 2019 | -372.78% |
| Sep 30, 2019 | -73.50% |
| Jun 30, 2019 | 64.39% |
| Mar 31, 2019 | 41.15% |
| Dec 31, 2018 | -48.24% |
| Sep 30, 2018 | 116.31% |
| Jun 30, 2018 | -54.18% |
| Mar 31, 2018 | 20.21% |
| Dec 31, 2017 | 187.10% |
| Sep 30, 2017 | -58.93% |
| Jun 30, 2017 | 228.43% |
| Mar 31, 2017 | -144.50% |
| Dec 31, 2016 | 264.40% |
| Sep 30, 2016 | 2,532.21% |
| Jun 30, 2016 | 103.83% |
| Mar 31, 2016 | -176.59% |
| Dec 31, 2015 | 63.91% |
| Sep 30, 2015 | -155.46% |
| Jun 30, 2015 | 384.12% |
| Mar 31, 2015 | 146.08% |
| Dec 31, 2014 | -130.52% |
| Sep 30, 2014 | 6,578.11% |
| Jun 30, 2014 | 96.82% |
| Mar 31, 2014 | -811.01% |
| Dec 31, 2013 | -132.77% |
| Sep 30, 2013 | -67.85% |
| Jun 30, 2013 | 238.68% |
| Mar 31, 2013 | -308.38% |
| Dec 31, 2012 | 407.02% |
| Sep 30, 2012 | -109.20% |
| Jun 30, 2012 | 189.77% |
| Mar 31, 2012 | -208.92% |
| Dec 31, 2011 | -179.48% |
| Mar 31, 2011 | 162.19% |
| Dec 31, 2010 | -240.61% |
| Sep 30, 2010 | 494.94% |
| Jun 30, 2010 | -17.40% |
| Mar 31, 2010 | 55.08% |
| Dec 31, 2009 | -173.57% |
| Sep 30, 2009 | 179.46% |
| Jun 30, 2009 | -189.38% |